Literature DB >> 22893359

Vascular factors predict polyneuropathy in a non-diabetic elderly population.

Marzia Baldereschi1, Marco Inzitari, Antonio Di Carlo, Francesca Bovis, Stefania Maggi, Antonio Capurso, Vincenzo Solfrizzi, Francesco Panza, Emanuele Scafato, Domenico Inzitari.   

Abstract

We prospectively examined whether vascular factors are related to an increased incidence of Chronic Idiopathic Distal Symmetric Neuropathy (CI-DSN) in a non-diabetic elderly population. In 8 Italian municipalities, 2,512 men and women without both diabetes and CI-DSN at baseline are examined. Potential effect of vascular factors was estimated by regressing new onset CI-DSN on the occurrence of several vascular diseases and risk factors. Multivariate relative risks of CI-DSN were estimated by Cox proportional hazards models. After 3.8 (±2.4) years of follow-up, we documented 51 incident CI-DSN cases. At univariate analysis, age, comorbidity, waist circumference, leg length, peripheral artery disease, and coronary heart disease proved to increase the risk of developing CI-DSN. By multivariate analyses, only age (RR = 1.08; 95 % CI, 1.02-1.14), leg length (RR = 1.05; 95 % CI, 1.01-1.1) and peripheral artery disease (RR = 2.75; 95 % CI, 1.15-6.56) proved significant predictors of CI-DSN. Separate analyses by gender show that age is an independent predictor of CI-DSN both in men and in women, while PAD predicts the disease only in men, together with body height. Incidence of CI-DSN is higher in individuals carrying vascular conditions. In men, the presence at baseline of peripheral artery disease is associated with a threefold increase in the risk of developing CI-DSN. The incidence of neuropathy in non-diabetic individuals is associated with potentially modifiable vascular factors.

Entities:  

Mesh:

Year:  2012        PMID: 22893359     DOI: 10.1007/s10072-012-1167-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  25 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 3.  Current concepts in neurology. The causes, classification, and treatment of peripheral neuropathy.

Authors:  P J Dyck
Journal:  N Engl J Med       Date:  1982-07-29       Impact factor: 91.245

4.  Lower extremity nerve function in patients with lower extremity ischemia.

Authors:  Mary M McDermott; Robert Sufit; Takashi Nishida; Jack M Guralnik; Luigi Ferrucci; Lu Tian; Kiang Liu; Jin Tan; William H Pearce; Joseph R Schneider; Leena Sharma; Michael H Criqui
Journal:  Arch Intern Med       Date:  2006-10-09

5.  Statins and risk of polyneuropathy: a case-control study.

Authors:  D Gaist; U Jeppesen; M Andersen; L A García Rodríguez; J Hallas; S H Sindrup
Journal:  Neurology       Date:  2002-05-14       Impact factor: 9.910

6.  Epidemiology of distal symmetrical neuropathies in the Italian elderly.

Authors:  M Baldereschi; M Inzitari; A Di Carlo; G Farchi; E Scafato; D Inzitari
Journal:  Neurology       Date:  2007-05-01       Impact factor: 9.910

7.  Progression of neuropathy in peripheral arterial disease.

Authors:  J D England; M A Ferguson; W R Hiatt; J G Regensteiner
Journal:  Muscle Nerve       Date:  1995-04       Impact factor: 3.217

8.  A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy.

Authors:  R A C Hughes; T Umapathi; I A Gray; N A Gregson; M Noori; A S Pannala; A Proteggente; A V Swan
Journal:  Brain       Date:  2004-06-16       Impact factor: 13.501

9.  The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy.

Authors:  Michael Polydefkis; Peter Hauer; Soham Sheth; Michael Sirdofsky; John W Griffin; Justin C McArthur
Journal:  Brain       Date:  2004-05-05       Impact factor: 13.501

10.  Impairments of muscles and nerves associated with peripheral arterial disease and their relationship with lower extremity functioning: the InCHIANTI Study.

Authors:  Mary McGrae McDermott; Jack M Guralnik; Monique Albay; Stefania Bandinelli; Benedetta Miniati; Luigi Ferrucci
Journal:  J Am Geriatr Soc       Date:  2004-03       Impact factor: 5.562

View more
  6 in total

Review 1.  Drug therapy for chronic idiopathic axonal polyneuropathy.

Authors:  Janna Warendorf; Alexander Fje Vrancken; Ivo N van Schaik; Richard Ac Hughes; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

2.  Sudomotor function in diabetic peripheral artery disease: a role for diabetic neuropathy?

Authors:  Pauline Poupon; Marie Monlun; Laure Alexandre; Laurence Blanco; Vincent Rigalleau
Journal:  Neurol Sci       Date:  2017-09-15       Impact factor: 3.307

3.  Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin.

Authors:  G T Russo; A Giandalia; E L Romeo; C Scarcella; N Gambadoro; R Zingale; F Forte; G Perdichizzi; A Alibrandi; D Cucinotta
Journal:  J Endocrinol Invest       Date:  2015-08-02       Impact factor: 4.256

4.  Conditions Associated with Essential Tremor in Veterans: A Potential Role for Chronic Stress.

Authors:  Adrian Handforth; Gail A Parker
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-05-17

5.  Study of Autophagy and Microangiopathy in Sural Nerves of Patients with Chronic Idiopathic Axonal Polyneuropathy.

Authors:  Kristin Samuelsson; Ayman A M Osman; Maria Angeria; Mårten Risling; Simin Mohseni; Rayomand Press
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

Review 6.  Microangiopathy-A Potential Contributing Factor to Idiopathic Polyneuropathy: A Mini Review.

Authors:  Kristin Samuelsson; Rayomand Press
Journal:  Front Neurol       Date:  2018-02-12       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.